Clinical question:Management recurrent, resectable CRC

ثبت نشده
چکیده

1 Background ................................................................................................................................................................ 1 1.1 The role of surgical treatment .......................................................................................................................... 2 1.2 The role of radiation treatment ........................................................................................................................ 2 2 Systematic review evidence ...................................................................................................................................... 4 2.1 Perioperative mortality, morbidity and adverse events .................................................................................... 5 2.2 Survival outcomes ............................................................................................................................................ 6 2.2.1 Overall survival ....................................................................................................................................... 6 2.2.2 Median survival ....................................................................................................................................... 6 2.2.3 Locoregional relapse-free survival .......................................................................................................... 6 2.3 Quality-of-life outcomes ................................................................................................................................... 6 3 Evidence summary and recommendations ................................................................................................................ 7 3.1 Considerations in making these recommendations .......................................................................................... 8 3.1.1 Limitations of the body of evidence ........................................................................................................ 9 3.1.2 Additional evidence from case series in rectal cancer ............................................................................ 9 3.1.3 Post-operative complications and quality of life ...................................................................................... 9 3.1.4 Cost effectiveness ................................................................................................................................. 10 3.1.5 Application of the evidence to colon cancer .......................................................................................... 10 3.2 Health system implications ............................................................................................................................. 10 3.2.1 Clinical practice ..................................................................................................................................... 10 3.2.2 Resourcing ............................................................................................................................................ 10 3.2.3 Barriers to implementation ................................................................................................................... 10 4 Discussion ................................................................................................................................................................ 11 4.1 Unresolved issues ........................................................................................................................................... 11 4.2 Studies currently underway ............................................................................................................................ 11 4.3 Future research priorities ............................................................................................................................... 11 5 References ............................................................................................................................................................... 11 6 Appendices .............................................................................................................................................................. 14

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Risk-stratified intensive follow up for treated colorectal cancer - realistic and cost saving?

OBJECTIVE Intensive follow-up post surgery for colorectal cancer (CRC) is thought to improve long-term survival principally through the earlier detection of recurrent disease. This paper aims to calculate the additional resource and cost implications of intensive follow up post-CRC resection, examine the possibility of risk-stratifying this follow up to those at highest risk of recurrence and i...

متن کامل

Multimodal Treatment of Recurrent Colorectal Cancer

Introduction: Recurrent disease following colorectal cancer surgery will occur in about 30-50% of patients when considering both locoregional relapse and distant metastasis. For patients with rectal cancer, preoperative chemoradiotherapy followed by TME can provide durable 10-years overall survival (OS) of 58% and recurrence-free survival (RFS) of 62%. Background: Despite optimal treatment with...

متن کامل

ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentation.

In 2009, an estimated 40,870 new cases of rectal cancer will be diagnosed in the USA. After decades of treating metastatic colorectal cancer (CRC) with 5-fluorouracil alone, newer agents have resulted in significant improvements in disease-free and overall survival rates. These improvements stem from combinations of newer cytotoxic agents and targeted therapies. Based on performance status and ...

متن کامل

Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery

Circulating tumour DNA (ctDNA) has the potential to be a specific biomarker for the monitoring of tumours in patients with colorectal cancer (CRC). Here, our aim was to develop a personalised surveillance strategy to monitor the clinical course of CRC after surgery. We developed patient-specific ctDNA assays based on multiplexed detection of somatic mutations identified from patient primary tum...

متن کامل

Micropapillary Pattern at the Invasive Front and Its Association with Unresectable Colorectal Carcinomas

Unresectable colorectal carcinomas (CRCs) as considered incurable even if the primary tumors and the metastatic ones can undergo resection are correlated with poor prognosis. We evaluated the association between micropapillary pattern at the invasive front and unresectable CRCs. Thirty-four out of 264 (12.9%) CRC patients with stages III and IV were unresectable cases. The patients with unresec...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2018